Prescription drug · NDA AUTHORIZED GENERIC
Methylprednisolone NDC 59762-0049
Methylprednisolone 8 mg/1 · Tablet · Oral · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59762-0049-1 | 59762004901 | 25 TABLET in 1 BOTTLE (59762-0049-1)Marketed from Mar 25, 2013 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methylprednisolone
- Generic name (nonproprietary)
- methylprednisolone
- Active ingredients
- Methylprednisolone — 8 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Mylan Pharmaceuticals Inc.
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 011153
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 59762-0049_bc3419a0-22a3-4eaf-a4f2-3133e9380663SPL ID bc3419a0-22a3-4eaf-a4f2-3133e9380663SPL set ID 22dd75d6-f89a-44f7-8ca6-b64c4e9806ddRxCUI 197971, 197973, 259966, 328161, 762675UNII X4W7ZR7023UPC 0359762005014, 0359762005113, 0359762444035
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459762004901followed by a unit qualifier and the quantityPackage 59762-0049-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may requir…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 011153
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Medrolmethylprednisolone | Methylprednisolone 16 mg/1 | TabletOral | Pharmacia & Upjohn Company LLC | 0009-0073 |
| Methylprednisolone | Methylprednisolone 4 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-2370 |
| Medrolmethylprednisolone | Methylprednisolone 4 mg/1 | TabletOral | Pharmacia & Upjohn Company LLC | 0009-0056 |
| Medrolmethylprednisolone | Methylprednisolone 2 mg/1 | TabletOral | Pharmacia & Upjohn Company LLC | 0009-0020 |
| Methylprednisolone | Methylprednisolone 32 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-0051 |
| Medrolmethylprednisolone | Methylprednisolone 8 mg/1 | TabletOral | Pharmacia & Upjohn Company LLC | 0009-0022 |
| Methylprednisolone | Methylprednisolone 16 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-0050 |
| Methylprednisolone | Methylprednisolone 4 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-4440 |
| Methylprednisolone | Methylprednisolone 4 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4213 |